BCL2 and epidermolysis bullosa: In support of this observation, multiplex immunofluorescence revealed a marked increase in BCL2 protein expression, specifically in GATA2-EB patients, compared to all other patient groups (the proportion of BCL2-positive cells mean ± SD in GATA2-EB was 0.